UAE announces new pharmaceutical rule to break medicine monopolies and lower drug costs
UAE announces new pharmaceutical rule to break medicine monopolies and lower drug costs is drawing significant interest across the industry.
Middle East News: The UAE has activated a landmark 2026 pharmaceutical rule that ends single-agent drug monopolies by requiring multiple authorised distributors for each medicine. Introduced under Federal Decree-Law No. (38) of 2024 and enforced by the Emirates Drug Establishment (EDE), the reform aims to cut medicine prices, prevent shortages, boost competition, attract global pharma investment, and strengthen the country’s healthcare and medicine supply chain.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Brazil's auto sales, production soar in February
- I played professional football, now I teach maths - it gives me just as much pride
- SC refuses to bar Zydus from selling biosimilar of BMS' cancer drug
- Everything you need to know about streaming F1 on Apple TV
Source: Original →